A Study to Evaluate the Ability of UB-612 COVID-19 Vaccine to Boost Immunity of Heterologous COVID-19 Vaccines.
Clinical trial NCT05167253 · WITHDRAWN
Trial details
- NCT number
- NCT05167253
- Sponsor
- United Biomedical Inc., Asia
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-15
- Primary completion
- 2022-04-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.